The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
2don MSN
Genetic risk factor and viral infection jointly contribute to multiple sclerosis, study suggests
Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...
A group of international experts is proposing a first-of-its-kind framework to prevent multiple sclerosis (MS) from ...
MedPage Today on MSN
Multiple Sclerosis Risk May Start Before Birth
Other prenatal exposures -- preterm birth (before 37 weeks gestation), placental abruption, and maternal hypertensive ...
Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.
ScienceAlert on MSN
Multiple sclerosis may have two distinct subtypes, scientists discover
There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...
News-Medical.Net on MSN
Rare immune events link Epstein Barr virus to early multiple sclerosis damage
The current study shows that the Epstein–Barr virus can interfere with the normal control of B cells. One viral protein ...
The immune system's reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple ...
Cannabis use may impair the ability of people with multiple sclerosis to accurately self-assess their cognitive performance.
Researchers at McMaster University in Hamilton are observing people with multiple sclerosis as they exercise while they play ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results